AUSTRALIAN healthcare manufacturer GMP Pharmaceuticals has completed extensive renovations and upgrades to its global headquarters in Huntingwood, Sydney, NSW.
GMP says its state-of-the-art facility now boasts a range of new features and improvements, including a new dry manufacturing facility that incorporates a quality in-process lab.
It allows the physical characteristic of the products to be verified online and ensures that every single tablet produced meets the product specification, GMP said.
The installation of a new sophisticated coating machine, and a new wet granulation suite enables GMP to perfectly control the uniformity of micro-dosed multivitamins, minerals, and other functional ingredients.
The entire site is temperature and humidity-controlled reaching ISO Class 8 standards for the site.
The enhancements are also seeing GMP lead the way in taking Australian-made dietary supplements to markets in the US, having recently been granted a license from the US Food and Drug Administration for Food Facility Registration.
Additionally, GMP has updated its TGA license variation to include new dosage forms such as effervescent tablets, enteric-coated tablets, film-coated tablets, modified-release tablets, granules, and hard capsules.
Pictured: GMP's renovated site.
The above article was sent to subscribers in Pharmacy Daily's issue from 09 Feb 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Feb 23
